NEPHROS, INC. Finite-Lived License Agreements, Gross
NEPHROS, INC. (NEPH) had Finite-Lived License Agreements, Gross of $2.30 million as of 2026-06-30, per its 10-Q filed 2026-08-10.
Financial Statements › Balance Sheet › Assets › Assets, Noncurrent › Intangible Asset, Excluding Goodwill, after Accumulated Amortization › Intangible Asset, Finite-Lived, after Accumulated Amortization › Intangible Asset, Finite-Lived, before Accumulated Amortization
us-gaap:FiniteLivedLicenseAgreementsGross · last filed 2026-08-10
- 2026-06-30: Finite-Lived License Agreements, Gross $2.30M.
- 2026-03-31: Finite-Lived License Agreements, Gross $2.30M.
- 2025-12-31: Finite-Lived License Agreements, Gross $2.30M.
- 2025-09-30: Finite-Lived License Agreements, Gross $2.30M.
| Period end | Finite-Lived License Agreements, Gross |
|---|---|
| 2026-06-30 | $2.30M 10-Q · filed 2026-08-10 |
| 2026-03-31 | $2.30M 10-Q · filed 2026-05-07 |
| 2025-12-31 | $2.30M 10-K · filed 2026-03-12 |
| 2025-09-30 | $2.30M 10-Q · filed 2025-11-06 |
| 2025-06-30 | $2.30M 10-Q · filed 2025-08-07 |
| 2025-03-31 | $2.30M 10-Q · filed 2025-05-15 |
| 2024-12-31 | $2.30M 10-K · filed 2025-03-24 |
| 2024-09-30 | $2.30M 10-Q · filed 2024-11-14 |
| 2024-06-30 | $2.30M 10-Q · filed 2024-08-08 |
| 2024-03-31 | $2.30M 10-Q · filed 2024-05-09 |
| 2023-12-31 | $2.30M 10-K · filed 2024-03-15 |
| 2023-09-30 | $2.30M 10-Q · filed 2023-11-08 |
| 2023-06-30 | $2.30M 10-Q · filed 2023-08-09 |
| 2023-03-31 | $2.30M 10-Q · filed 2023-05-10 |
| 2022-12-31 | $2.30M 10-K · filed 2023-03-23 |
| 2022-09-30 | $2.30M 10-Q · filed 2022-11-15 |
| 2022-06-30 | $2.30M 10-Q · filed 2022-08-15 |
| 2022-03-31 | $2.30M 10-Q · filed 2022-05-05 |
| 2021-12-31 | $2.30M 10-K · filed 2022-03-03 |
| 2021-09-30 | $2.30M 10-Q · filed 2021-11-04 |
| 2021-06-30 | $2.30M 10-Q · filed 2021-08-05 |
| 2021-03-31 | $2.30M 10-Q · filed 2021-05-06 |
| 2020-12-31 | $2.30M 10-K · filed 2021-03-01 |
| 2020-09-30 | $2.30M 10-Q · filed 2020-11-05 |
| 2020-06-30 | $2.30M 10-Q · filed 2020-08-05 |
| 2020-03-31 | $2.30M 10-Q · filed 2020-05-06 |
| 2019-12-31 | $2.25M 10-K · filed 2020-02-27 |
| 2019-09-30 | $2.25M 10-Q · filed 2019-11-06 |
| 2019-06-30 | $2.25M 10-Q · filed 2019-08-07 |
| 2019-03-31 | $2.25M 10-Q · filed 2019-05-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Sensus Healthcare, Inc. (SRTS) | United States | $0.048B | -3.24 |
| SANUWAVE Health, Inc. (SNWV) | United States | $0.041B | 5.47 |
| Spectral AI, Inc. (MDAI) | United States | $0.052B | |
| Xtant Medical Holdings, Inc. (XTNT) | United States | $0.053B | |
| TELA Bio, Inc. (TELA) | United States | $0.057B | -0.82 |
| InspireMD, Inc. (NSPR) | $0.033B | ||
| PAVmed Inc. (PAVM) | United States | $0.031B | -3.00 |
| Glucotrack, Inc. (GCTK) | United States | $0.027B | |
| ACCURAY INC (ARAY) | United States | $0.027B | -0.63 |
| DarioHealth Corp. (DRIO) | $0.066B | -1.39 |